THE MODE OF SECRETION OF ALPHA -AMYLASE IN BARLEY ALEURONE LAYERSLOCY R; KENDE M.1978; PLANTA; DEU; DA. 1978; VOL. 143; NO 1; PP. 89-99; BIBL. 28 REF.Article

B.K. VIRUS HOEMAGGLUTININKENDE M; UJ M; SZUECS G et al.1979; ACTA MICROBIOL. ACAD. SCI. HUNGAR; HUN; DA. 1979; VOL. 26; NO 3; PP. 179-184; BIBL. 16 REF.Article

HAEMAGGLUTINATION-INHIBITING ANTIBODIES TO B.K. VIRUS IN HUNGARYSZUECS G; KENDE M; UEJ M et al.1979; ACTA MICROBIOL. ACAD. SCI. HUNGAR; HUN; DA. 1979; VOL. 26; NO 3; PP. 173-178; BIBL. 20 REF.Article

THERAPY OF AKR LEUKEMIA WITH ANTIBODY-DEPENDENT NORMAL LYMPHOCYTES AND CYCLOPHOSPHAMIDE.PUTMAN DL; KIND PD; KENDE M et al.1977; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1977; VOL. 3; NO 2; PP. 97-99; BIBL. 16 REF.Article

Monopoly incentives to license a product with network externalities = Les incitations pour un monopole à accorder une licence de produit avec externalités de réseauKENDE, M.1992, 20 p.Book

Government support of the European information technology industry = Aide publique à l'industrie européenne des technologies de l'informationKENDE, M.1996, 36 p.Book

Gains from standardization: the case of numerical controls = Les bénéfices issus de la standardisation: le cas des contrôles numériquesKENDE, M.1991, 57 p.Book

NATURALLY OCCURRING HUMORAL IMMUNITY TO ENDOGENOUS XENOTROPIC AND AMPHOTROPIC TYPE-C VIRUS IN THE MOUSEKENDE M; VERONESE F; HILL DW et al.1981; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1981; VOL. 27; NO 2; PP. 235-242; BIBL. 2 P.Article

TYPE-C VIRUS STRUCTURAL ANTIGENS ON THE SURFACE OF THE INFECTED CELL AS DETERMINED BY A HUMORAL CYTOTOXICITY ASSAY.KENDE M; SASS B; HINO S et al.1978; INTERNATION. J. CANCER; SWITZ.; DA. 1978; VOL. 21; NO 2; PP. 194-203; ABS. FR.; BIBL. 31 REF.Article

Licensing and the battle between standards = L'autorisation de licence et la bataille entre les standardsKENDE, M.1995, 24 p.Book

A note on backward compatibility = Note sur la compatibilité rétroactiveKENDE, M.1993, 11 p.Book

NATURALLY OCCURRING LYMPHOCYTE MEDIATED IMMUNITY TO ENDOGENOUS TYPE-C VIRUS IN THE MOUSE. BLOCKING OF THE LYMPHOCYTE REACTIVITY WITH ANTISERA TO THE VIRUSKENDE M; HILL R; DINOWITZ M et al.1979; J. EXPER. MED.; USA; DA. 1979; VOL. 149; NO 2; PP. 358-371; BIBL. 47 REF.Article

DRUG-MEDIATED IMMUNOGENIC CHANGES OF VIRUS-INDUCED LEUKEMIA IN VIVOHOUCHENS DP; BONMASSAR E; GASTON MR et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1347-1352; BIBL. 17 REF.Article

IMMUNOCHEMOTHERAPY OF TRANSPLANTABLE MOLONEY LEUKEMIA WITH CYCLOPHOSPHAMIDE AND ALLOGENEIC SPLEEN LYMPHOCYTES AND REVERSAL OF GRAFT VERSUS-HOST DISEASE WITH ALLOANTISERUM = IMMUNOCHIMIOTHERAPIE DE LA LEUCEMIE DE MOLONEY TRANSPLANTABLE AVEC LE CYCLOPHOSPHAMIDE ET DES LYMPHOCYTES SPLENIQUES ALLOGENIQUES ET ANTAGONISME DE LA MALADIE DE LA GREFFE CONTRE L'HOTE AVEC L'ALLOANTISERUMKENDE M; KEYS LD; GASTON M et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 2; PP. 346-351; BIBL. 21REF.Article

IMMUNOPREVENTION OF NATURALLY OCCURRING ENDOGENOUS MURINE TYPE-C RNA VIRUSES.KENDE M; STEPHENSON JR; KELLOFF GJ et al.1978; NATURE; G.B.; DA. 1978; VOL. 273; NO 5661; PP. 383-385; BIBL. 30 REF.Article

The dynamics of technological adoption in hardware/software systems : the case of compact disc players = La dynamique de l'adoption de technologie dans les systèmes hardware/software : le cas du lecteur de compact disquesGANDAL, N; KENDE, M; ROB, R et al.1997, 37 p.Book

Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in miceZVILICH, M; WILLIAMS, J. C; WAAG, D et al.Antiviral research. 1995, Vol 27, Num 1-2, pp 137-149, issn 0166-3542Article

Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion techniqueCHANGHONG YAN; RESAU, J. H; HEWETSON, J et al.Journal of controlled release. 1994, Vol 32, Num 3, pp 231-241, issn 0168-3659Article

Injection of inactivated phase I Coxiella burnetii increases non-specific resistance to infection and stimulates lymphokine production in miceWAAG, D. M; KENDE, M; DAMROW, T. A et al.Annals of the New York Academy of Sciences. 1990, Vol 590, pp 203-214, issn 0077-8923, 12 p.Conference Paper

Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against rift valley fever virus infection in miceKENDE, M; LUPTON, H. W; RILL, W. L et al.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 7, pp 986-990, issn 0066-4804Article

Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriersYAN, C; RILL, W. L; MALLI, R et al.Vaccine. 1995, Vol 13, Num 7, pp 645-651, issn 0264-410XArticle

A comparison of pyrimidinone analogue immunomodulators for treatment of Phlebovirus infections in miceSIDWELL, R. W; HUFFMAN, J. H; COOMBS, J et al.Antiviral chemistry & chemotherapy. 1990, Vol 1, Num 4, pp 241-247, issn 0956-3202, 7 p.Article

Different electrophoretypes of human rotaviruses in HungarySZUCS, G; KENDE, M; UJ, M et al.Acta virologica (English ed.). 1987, Vol 31, Num 5, pp 369-373, issn 0001-723XArticle

Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in miceSMEE, D. F; SIDWELL, R. W; HUFFMAN, J. H et al.Chemotherapy (Basel). 1996, Vol 42, Num 4, pp 286-293, issn 0009-3157Article

Antiviral immunotoxins : antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitroBARNETT, B. B; BURNS, N. J; PARK, K. J et al.Antiviral research. 1991, Vol 15, Num 2, pp 125-138, issn 0166-3542, 14 p.Article